DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Biologic Drugs cited in Phoenix Licensing, L.L.C. v. Aetna Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2011-08-15||52||communications or replies. („938 Patent at 43:25-47, 57:10-30, 60:60 – 62:64). No specific machine or…Specifically, one of the two patents-in-suit, U.S. Patent No. 6,999,938 (“the „938 Patent”) includes steps such…Similarly, the other patent-in- suit, U.S. Patent No. 7,890,366 (“the „366 Patent”), includes steps such…of the massive cost of patent lawsuits, the holders of patents directed to patent ineligible abstract … Patentable Subject Matter Under Section 101 That a patent be directed to patentable subject||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|